Halozyme Therapeutics HALO
112.2
1.28
1.15
%
已收盤:07/23 20:00 (臺灣)
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
---|---|---|---|---|---|---|
2025Q1 | 63.81 | 95.40 | 17.70 | 0.93 | 141,535 | 118 |
2024Q4 | 47.81 | 96.03 | 13.70 | 1.06 | 175,501 | 137 |
2024Q3 | 57.24 | 96.18 | 18.48 | 1.05 | 163,197 | 137 |
2024Q2 | 52.36 | 95.88 | 20.90 | 0.72 | 117,235 | 93 |
2024Q1 | 40.68 | 95.03 | 18.32 | 0.60 | 95,542 | 77 |
2023Q4 | 36.96 | 94.96 | 19.23 | 0.65 | 101,035 | 85 |
2023Q3 | 38.20 | 83.07 | 21.56 | 0.61 | 88,279 | 82 |
2023Q2 | 36.07 | 96.73 | 20.32 | 0.55 | 94,458 | 75 |
2023Q1 | 38.19 | 94.75 | 28.43 | 0.29 | 53,802 | 40 |
2022Q4 | 56.90 | 98.87 | 36.43 | 0.42 | 74,509 | 58 |
2022Q3 | 39.54 | 102.55 | 15.04 | 0.44 | 83,292 | 62 |
2022Q2 | 44.00 | 102.85 | 13.96 | 0.15 | 34,060 | 23 |
2022Q1 | 39.88 | 99.35 | 13.64 | 0.43 | 75,670 | 60 |
2021Q4 | 40.21 | 99.42 | 0.46 | 56,534 | 67 | |
2021Q3 | 40.68 | 99.64 | 1.47 | 75,586 | 217 | |
2021Q2 | 45.41 | 99.76 | 0.62 | 93,047 | 91 | |
2021Q1 | 41.69 | 168.83 | 0.19 | 50,735 | 28 | |
2020Q4 | 42.71 | 99.16 | 0.51 | 77,624 | 73 | |
2020Q3 | 26.28 | 97.67 | 0.26 | 40,299 | 36 | |
2020Q2 | 26.81 | 95.71 | 0.18 | 29,555 | 26 |